Higher Caspase-like activity in symptomatic isolates of Blastocystis spp

Particle and Fibre Toxicology

Suresh G Kumar¹  Dhurga D Balakrishnan¹ 

[1] Department of Parasitology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia

关键词: Metronidazole;    Programmed cell death;    Caspase-like proteases;    Asymptomatic;    Symptomatic;    Apoptosis;    Blastocystis spp;   

Others  :  819811
DOI  :  10.1186/1756-3305-7-219

 received in 2013-10-11, accepted in 2014-01-02,  发布年份 2014

【 摘 要 】

Background

Biochemical evidence of a caspase-like execution pathway has been demonstrated in a variety of protozoan parasites, including Blastocystis spp. The distinct differences in the phenotypic characterization reported previously have prompted us to compare the rate of apoptosis in Blastocystis spp. isolated from individuals who were symptomatic and asymptomatic. In the current study, we analysed the caspase activation involved in PCD mediated by a cytotoxic drug, (metronidazole) in both symptomatic & asymptomatic isolates.

Methods

Apoptosis was induced in Blastocystis spp. by treating cultures of symptomatic and asymptomatic isolates of 3 sub-types namely 1, 3 and 5 with two different concentrations, 0.1 and 0.0001 mg/ml of metronidazole (with and without pre-treatment with a pan-caspase inhibitor, zVAD.fmk). The experiment was repeated to assess the number of apoptotic cells in all the isolates of both conditions.

Results

Symptomatic isolates of subtype 3 (without pre-treatment with a pan-caspase inhibitor, zVAD.fmk) showed high fluorescence intensity for active caspase-like proteases [0.0001 mg/ml, 88% (p < 0.001) at 0.1 mg/ml, 70% (p < 0.001)] at the 72^nd hour in vitro culture in comparison with asymptomatic isolates [0.0001 mg/ml, 65%, at 0.1 mg/ml, 55%]. The number of apoptotic cells was higher [0.0001 mg/ml, 89% (p < 0.001) and at 0.1 mg/ml, 70% (p < 0.001)] at the 72^nd hour of in vitro culture in comparison with asymptomatic isolates [0.0001 mg/ml, 66% (p < 0.001) and at 0.1 mg/ml, 45% (p < 0.01)]. Cells treated with metronidazole in the presence of zVAD.fmk showed less than 10% caspase activation.

Conclusion

The high number of symptomatic cells expressing active caspase-like proteases and becoming apoptotic compared to asymptomatic cells clearly demonstrates that the response to metronidazole treatment is isolate dependent. Hence this justifies the conflicting reports on the curative success rates when treated with this drug. The study has also created a need to identify apoptosis effectors in Blastocystis spp of different isolates especially as it was shown that apoptosis was sub-typed related. These findings can be exploited for the development of diagnostic markers and novel therapeutic drugs to enhance the effectiveness of the diagnosis and treatment of the patients infected with Blastocystis spp.

【 授权许可】

   
2014 Balakrishnan and Kumar; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Riedl SJ, Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Bio 2004, 5(11):897-907.
• [2]Daniel D, Opelz G, Mulder A, Kleist C, Süsal C: Pathway of apoptosis induced in Jurkat T lymphoblasts by anti-HLA class I antibodies. Hum Immunol 2004, 65(3):189-199.
• [3]Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME, Debatin K-M: Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem 1998, 273(51):33942-33948.
• [4]Nasirudeen A, Tan KS: Caspase-3-like protease influences but is not essential for DNA fragmentation in Blastocystis undergoing apoptosis. Eur J Cell Biol 2004, 83(9):477-482.
• [5]Tan KS, Mirza H, Teo JD, Wu B, MacAry PA: Current views on the clinical relevance of Blastocystis spp. Infect Dis Rep 2010, 12(1):28-35.
• [6]Stensvold C, Lewis H, Hammerum A, Porsbo L, Nielsen S, Olsen K, Arendrup M, Nielsen H, Mølbak K: Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite. Epidemiol Infect 2009, 1:12.
• [7]Katsarou-Katsari A, Vassalos CM, Tzanetou K, Spanakos G, Papadopoulou C, Vakalis N: Acute urticaria associated with amoeboid forms of Blastocystis sp. subtype 3. Acta Derm Venereol 2008, 88(1):80-81.
• [8]Valsecchi R, Leghissa P, Greco V: Cutaneous lesions in Blastocystis hominis infection. Acta Derm Venereol 2004, 84(4):322-323.
• [9]Zierdt CH, Tan HK: Ultrastructure and light microscope appearance ofBlastocystis hominis in a patient with enteric disease. Z Parasitenkde 1976, 50(3):277-283.
• [10]Sun T, Katz S, Tanenbaum B, Schenone C: Questionable clinical significance of Blastocystis hominis infection. Am J Gastroentero 1989, 84(12):1543-1547.
• [11]Llibre J, Tor J, Manterola J, Carbonell C, Foz M: Blastocystis hominis chronic diarrhoea in AIDS patients. Lancet 1989, 333(8631):221.
• [12]Dhurga D, Suresh K, Tan T, Chandramathi S: Apoptosis in Blastocystis spp. is related to subtype. T Roy Soc Trop Med H 2012, 106(12):725-730.
• [13]Tan T, Suresh K, Smith H: Phenotypic and genotypic characterisation of Blastocystis hominis isolates implicates subtype 3 as a subtype with pathogenic potential. Parasitol Res 2008, 104(1):85-93.
• [14]Fröhlich K-U, Madeo F: Apoptosis in yeast–a monocellular organism exhibits altruistic behaviour. FEBS lett 2000, 473(1):6-9.
• [15]Freshney RI: Culture of animal cells: a manual of basic technique. New York: Wiley; 1994.
• [16]Yoshikawa H, Wu Z, Kimata I, Iseki M, Ali IKM, Hossain MB, Zaman V, Haque R, Takahashi Y: Polymerase chain reaction-based genotype classification among human Blastocystis hominis populations isolated from different countries. Parasitol Res 2004, 92(1):22-29.
• [17]Salvesen GS, Renatus M: Apoptosome: the seven-spoked death machine. Dev Cell 2002, 2(3):256-257.
• [18]Denault J-B, Salvesen GS: Caspases: keys in the ignition of cell death. Chem Rev 2002, 102(12):4489-4500.
• [19]Earnshaw WC, Martins LM, Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999, 68(1):383-424.
• [20]Nasirudeen A, Hian YE, Singh M, Tan KS: Metronidazole induces programmed cell death in the protozoan parasite Blastocystis hominis. Microbiology 2004, 150(1):33-43.
• [21]Mathiasen IS, Jäättelä M: Triggering caspase-independent cell death to combat cancer. Trends Mol Med 2002, 8(5):212-220.
• [22]Godefroy N, Lemaire C, Renaud F, Rincheval V, Perez S, Parvu-Ferecatu I, Mignotte B, Vayssiere J: p53 can promote mitochondria-and caspase-independent apoptosis. Cell Death Differ 2004, 11(7):785-787.
• [23]Land KM, Johnson PJ: Molecular basis of metronidazole resistance in pathogenic bacteria and protozoa. Drug Resist Updat 1999, 2(5):289-294.
• [24]Kulda J: Trichomonads, hydrogenosomes and drug resistance. Int J Parasitol 1999, 29(2):199-212.
• [25]Haresh K, Suresh K, Anuar AK, Saminathan S: Isolate resistance of Blastocystis hominis to metronidazole. Trop Med Int Health 1999, 4(4):274-277.
• [26]Taylor-Brown E, Hurd H: The first suicides: a legacy inherited by parasitic protozoans from prokaryote ancestors. Parasit Vectors 2013, 6(1):108. BioMed Central Full Text
• [27]Ameisen JC: On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ 2002, 9(4):367-393.
• [28]Deponte M, Becker K: Plasmodium falciparum do killers commit suicide? Trends Parasitol 2004, 20(4):165-169.